Marc Pritzker

4.2k total citations
96 papers, 2.9k citations indexed

About

Marc Pritzker is a scholar working on Surgery, Cardiology and Cardiovascular Medicine and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Marc Pritzker has authored 96 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 49 papers in Surgery, 49 papers in Cardiology and Cardiovascular Medicine and 31 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Marc Pritzker's work include Pulmonary Hypertension Research and Treatments (28 papers), Mechanical Circulatory Support Devices (27 papers) and Cardiac Structural Anomalies and Repair (25 papers). Marc Pritzker is often cited by papers focused on Pulmonary Hypertension Research and Treatments (28 papers), Mechanical Circulatory Support Devices (27 papers) and Cardiac Structural Anomalies and Repair (25 papers). Marc Pritzker collaborates with scholars based in United States, Poland and Canada. Marc Pritzker's co-authors include Thenappan Thenappan, Kurt W. Prins, David G. Benditt, Ε. Kenneth Weir, Monica Colvin, Ranjit John, Ann Dunnigan, Robert C. Bourge, D. Woodrow Benson and Andrew Boyle and has published in prestigious journals such as Circulation, Annals of Internal Medicine and Journal of the American College of Cardiology.

In The Last Decade

Marc Pritzker

90 papers receiving 2.8k citations

Peers

Marc Pritzker
Michael Ragosta United States
Hans Eiskjær Denmark
Andrew Jabbour Australia
Keyur B. Shah United States
Olivier C. Manintveld Netherlands
Khaled M. Ziada United States
Linda J. Addonizio United States
Alina A. Constantinescu Netherlands
Daniel A. Steinbrüchel Denmark
Wayne Tymchak Canada
Michael Ragosta United States
Marc Pritzker
Citations per year, relative to Marc Pritzker Marc Pritzker (= 1×) peers Michael Ragosta

Countries citing papers authored by Marc Pritzker

Since Specialization
Citations

This map shows the geographic impact of Marc Pritzker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marc Pritzker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marc Pritzker more than expected).

Fields of papers citing papers by Marc Pritzker

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marc Pritzker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marc Pritzker. The network helps show where Marc Pritzker may publish in the future.

Co-authorship network of co-authors of Marc Pritzker

This figure shows the co-authorship network connecting the top 25 collaborators of Marc Pritzker. A scholar is included among the top collaborators of Marc Pritzker based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marc Pritzker. Marc Pritzker is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Woolley, Joshua R., Guruprasad A. Giridharan, Alexander Rothman, et al.. (2025). Development of a Novel, Pulmonary Endovascular Device to Treat Patients With Pulmonary Hypertension. Pulmonary Circulation. 15(3). e70131–e70131.
2.
Gerges, Christian, Nika Skoro‐Sajer, Varius Dannenberg, et al.. (2024). Efficacy and safety of the Aria pulmonary endovascular device in pulmonary hypertension. European Heart Journal. 45(Supplement_1).
3.
Shaffer, Andrew, Ranjit John, Andrew S. Wechsler, et al.. (2021). First Successful LVAD Implantation After BioVentrix Revivent TC Ventricular Reshaping. The Annals of Thoracic Surgery. 112(2). e123–e126. 1 indexed citations
4.
Keen, Jennifer, et al.. (2021). Iron Deficiency Is Associated With More Severe Pulmonary Vascular Disease in Pulmonary Hypertension Caused by Chronic Lung Disease. CHEST Journal. 161(1). 232–236. 13 indexed citations
5.
Rose, Lauren, Kurt W. Prins, Stephen L. Archer, et al.. (2018). Survival in pulmonary hypertension due to chronic lung disease: Influence of low diffusion capacity of the lungs for carbon monoxide. The Journal of Heart and Lung Transplantation. 38(2). 145–155. 47 indexed citations
6.
Prins, Kurt W., Ε. Kenneth Weir, Stephen L. Archer, et al.. (2016). Pulmonary Pulse Wave Transit Time is Associated with Right Ventricular–Pulmonary Artery Coupling in Pulmonary Arterial Hypertension. Pulmonary Circulation. 6(4). 576–585. 26 indexed citations
7.
Adatya, Sirtaz, Megan J. Fitzpatrick, Monica Colvin, et al.. (2016). Coagulation factor abnormalities related to discordance between anti-factor Xa and activated partial thromboplastin time in patients supported with continuous-flow left ventricular assist devices. The Journal of Heart and Lung Transplantation. 35(11). 1311–1320. 13 indexed citations
8.
Thenappan, Thenappan, et al.. (2016). The Critical Role of Pulmonary Arterial Compliance in Pulmonary Hypertension. Annals of the American Thoracic Society. 13(2). 276–284. 141 indexed citations
9.
Kwon, Younghoon, Mardi Gomberg‐Maitland, Marc Pritzker, & Thenappan Thenappan. (2016). Telangiectasia and Pulmonary Arterial Hypertension Following Treatment With Trastuzumab Emtansine. CHEST Journal. 149(4). e103–e105. 20 indexed citations
10.
11.
Pritzker, Marc, et al.. (2013). Cardiovascular Risk and Psoriasis: Beyond the Traditional Risk Factors. The American Journal of Medicine. 127(1). 12–18. 65 indexed citations
12.
Lee, Sangjin, Forum Kamdar, Richard Madlon‐Kay, et al.. (2010). Effects of the HeartMate II continuous-flow left ventricular assist device on right ventricular function. The Journal of Heart and Lung Transplantation. 29(2). 209–215. 98 indexed citations
13.
Bunte, Matthew C., Mrinal M. Patnaik, Marc Pritzker, & Linda J. Burns. (2008). Pulmonary veno-occlusive disease following hematopoietic stem cell transplantation: a rare model of endothelial dysfunction. Bone Marrow Transplantation. 41(8). 677–686. 53 indexed citations
14.
Beek, Allen L. Van, et al.. (2006). Management of Vasospastic Disorders with Botulinum Toxin A. Plastic & Reconstructive Surgery. 119(1). 217–226. 105 indexed citations
15.
Pritzker, Marc, et al.. (2005). MRI Pulmonary Angiograms. CHEST Journal. 128(6). 630S–630S. 1 indexed citations
16.
Lake, Kathleen D., Smith Rjh, Sylvain Forest, Marc Pritzker, & Robert W. Emery. (1997). Outcomes of hepatitis C positive (HCV+) heart transplant recipients. Transplantation Proceedings. 29(1-2). 581–582. 22 indexed citations
17.
Emery, Robert W., Lyle D. Joyce, Mikel Prieto, et al.. (1992). Experience with the symbion total artificial heart as a bridge to transplantation. The Annals of Thoracic Surgery. 53(2). 282–288. 6 indexed citations
18.
Emery, Robert W., et al.. (1991). Treatment of End-Stage Chronic Obstructive Pulmonary Disease with Double Lung Transplantation*. CHEST Journal. 99(3). 533–537. 8 indexed citations
19.
Goldenberg, Irvin F., Adrian K. Almquist, Marc Pritzker, et al.. (1989). Intravenous amiodarone for the rapid treatment of life-threatening ventricular arrhythmias in critically ill patients with coronary artery disease. The American Journal of Cardiology. 64(10). 599–603. 46 indexed citations
20.
Benditt, David G., D. Woodrow Benson, George J. Klein, et al.. (1983). Prevention of recurrent sudden cardiac arrest: role of provocative electropharmacologic testing. Journal of the American College of Cardiology. 2(3). 418–425. 90 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Michael Ragosta Breakdown of academic impact, for papers by Hans Eiskjær Breakdown of academic impact, for papers by Andrew Jabbour Breakdown of academic impact, for papers by Keyur B. Shah Breakdown of academic impact, for papers by Olivier C. Manintveld Breakdown of academic impact, for papers by Khaled M. Ziada Breakdown of academic impact, for papers by Linda J. Addonizio Breakdown of academic impact, for papers by Alina A. Constantinescu Breakdown of academic impact, for papers by Daniel A. Steinbrüchel Breakdown of academic impact, for papers by Wayne Tymchak
Rankless by CCL
2026